🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Seli Sikiilii › California

Qorannoo klinikaalii Dhibee Seli Sikiilii California keessatti

Qorannoo 19 Dhibee Seli Sikiilii f California keessatti hirmaatuu jiru.

Magaalota California keessatti

Takkalaa qorannoo (Ingiliffa)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • University of California San Francisco (UCSF) Medical Center, San Francisco
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973

Exercise in Child Health

  • University of California, Irvine, Irvine
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05359991

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Ctr for Inherited Blood Disorders, Orange
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  • Children's Hospital Los Angeles - Endocrinology, Los Angeles
  • UCSF Oakland Benioff ChildHosp, Oakland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Hospital Los Angeles - Endocrinology, Los Angeles
  • Valley Children's Hospital, Madera
  • Stanford University_Palo Alto, Palo Alto
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

  • Harbor UCLA Medical Center, Torrance
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 5 hanga 20 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07369024

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • University of California San Diego - La Jolla, La Jolla
  • UCSF Benioff Children's Hospital Oakland, Oakland
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Orthopaedic Institute for Children HTC, Los Angeles
  • Childrens Hospital Los Angeles, Los Angeles
  • UCSF Benioff Children's Hospital Oakland, Oakland
  • fi 5 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • Univ. of California, San Francisco Health Care, Oakland
  • University of California Irvine, Orange
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • University of California Irvine, Orange
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07224360

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  • University of California San Francisco- Site Number : 8400040, Fresno
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06975865

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

  • University of California Los Angeles, Los Angeles
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 21 Years · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT02675959

Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

  • UC Davis Comprehensive Cancer Center, Sacramento
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT06016634

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

  • Children's Hospital Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital, Palo Alto
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 50 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT04819841

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

  • City of Hope Medical Center, Duarte
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT03279094

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

  • University of California, Los Angeles, Los Angeles
  • UCSF Benioff Children's Hospital, Oakland
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 35 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT04774536

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • UCSF Benioff Children's Hospital Oakland, Oakland
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 40 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06260891

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • UCLA Mattel Children's Hospital Ronald Reagan Hospital, Los Angeles
Namoota walitti qabaa jira
Umuriin 16 hanga 30 · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06374238

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of California, San Francisco (UCSF), Oakland
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Wax-2025 · NCT06385886

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.